Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01866410 |
Title | Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | National Cancer Institute (NCI) |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
City of Hope Comprehensive Cancer Center | Duarte | California | 91010 | United States | Details | |
USC / Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | United States | Details | |
University of California Davis Comprehensive Cancer Center | Sacramento | California | 95817 | United States | Details | |
City of Hope South Pasadena | South Pasadena | California | 91030 | United States | Details | |
Wayne State University/Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
Penn State Milton S Hershey Medical Center | Hershey | Pennsylvania | 17033-0850 | United States | Details | |
University of Pittsburgh Cancer Institute (UPCI) | Pittsburgh | Pennsylvania | 15232 | United States | Details |